AVITA Medical, Inc. has appointed Cary Vance as Interim CEO and Jan Stern Reed as Lead Independent Director. The company expects third quarter revenue to be around $17 million. The Board is initiating a search for a permanent CEO and is in discussions to redefine future covenants with OrbiMed. AVITA Medical focuses on wound care solutions, including the RECELL System. Mr. Vance, with over 30 years of healthcare experience, is excited to lead the company during this important time. The Company will provide an update on third-quarter earnings on November 6, 2025.

Read more at GlobeNewswire: AVITA Medical Announces CEO Transition